The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone

gan Bamberg, Krister, William-Olsson, Lena, Johansson, Ulrika, Jansson-Löfmark, Rasmus, Hartleib-Geschwindner, Judith
Cyhoeddwyd yn J Renin Angiotensin Aldosterone Syst (2019)

Electrolyte handling in the isolated perfused rat kidney: demonstration of vasopressin V2-receptor-dependent calcium reabsorption

gan Bamberg, Krister, William-Olsson, Lena, Johansson, Ulrika, Arner, Anders, Hartleib-Geschwindner, Judith, Sällström, Johan
Cyhoeddwyd yn Ups J Med Sci (2020)

Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator

gan Erlandsson, Fredrik, Albayaty, Muna, Chialda, Ligia, Ericsson, Hans, Amilon, Carl, Nelander, Karin, Jansson‐Löfmark, Rasmus, Wernevik, Linda, Kjaer, Magnus, Bamberg, Krister, Hartleib‐Geschwindner, Judith
Cyhoeddwyd yn Br J Clin Pharmacol (2018)

Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study

gan Whittaker, Andrew, Kragh, Åsa M., Hartleib‐Geschwindner, Judith, Albayaty, Muna, Backlund, Anna, Greasley, Peter J., Heijer, Maria, Kjaer, Magnus, Forte, Pablo, Unwin, Robert, Wernevik, Linda, Ericsson, Hans
Cyhoeddwyd yn Clin Transl Sci (2019)

Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion

gan Bamberg, Krister, Johansson, Ulrika, Edman, Karl, William-Olsson, Lena, Myhre, Susanna, Gunnarsson, Anders, Geschwindner, Stefan, Aagaard, Anna, Björnson Granqvist, Anna, Jaisser, Frédéric, Huang, Yufeng, Granberg, Kenneth L., Jansson-Löfmark, Rasmus, Hartleib-Geschwindner, Judith
Cyhoeddwyd yn PLoS One (2018)